Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1998-05-05
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 530300, A61K 5100, A61M 3614
Patent
active
057469962
ABSTRACT:
A method of radiolabeling a peptide, e.g., somatostatin or an analogue thereof or vasoactive intestinal peptide, with a radioisotope of technetium or rhenium, comprises the steps of: (a) reacting the peptide with an acetyl-protected t-thiol-containing, amine-reactive bifunctional chelating agent; (b) deprotecting the acetyl-t-thiol group to generate a free t-thiol group; and either (c) admixing the peptide-t-thiol-containing conjugate with a stannous salt; and (d) reacting the mixture of step (c) with pertechnetate or perrhenate, or (c') adding reduced pertechnetate or perrhenate to said peptide-t-thiol-containing conjugate, thereby forming a radiolabeled peptide. Kits for effecting the radiolabeling method, and methods of tumor detection/imaging or therapy are provided.
REFERENCES:
patent: 4323546 (1982-04-01), Crockford et al.
patent: 4424200 (1984-01-01), Crockford et al.
patent: 4883862 (1989-11-01), Chervu et al.
patent: 4932412 (1990-06-01), Goldenberg
patent: 5026913 (1991-06-01), McBride et al.
patent: 5061641 (1991-10-01), Shochat et al.
patent: 5080884 (1992-01-01), McBride et al.
patent: 5082930 (1992-01-01), Nicolotti et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5102990 (1992-04-01), Rhodes
patent: 5128119 (1992-07-01), Griffiths
patent: 5180816 (1993-01-01), Dean
patent: 5196515 (1993-03-01), Lever et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5242679 (1993-09-01), Fritzberg et al.
patent: 5245018 (1993-09-01), Kondo et al.
patent: 5310536 (1994-05-01), Srinivasan
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5395946 (1995-03-01), Goedemans et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
Greenfield, et al. "Thiol-Containing Cross-Linking Agent with Enhanced Steric Hindrance," Bioconjugate Chem. 1, 400-10 (1990).
Khaw et al.--J. Nucl. Med. 23:1011-19 (1982), "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen".
Khaw et al.--Science, 209:295-97 (1980), "Myocardial Infarct Imaging of Antibodies to Canine Cardiac Myosin with Indium-111-Diethylenetriamine Pentaacetic Acid".
Krejcarek, et al.--Biochem. Byophys. Res. Commun., 77:581-85 (1977), "Covalent Attachment of Chelating Groups to Macromolecules".
Childs, et al.--J. Nucl. Med., 26:293 (1985), "Optimum Conditions for Labeling of DTPA Coupled Antibodies with Technetium-99m".
Fritzberg, et al.--J. Nucl. Med., 27:957, (1986), "Radiopharmaceutical Chemistry v. Antibodies".
Baidoo, et al.--Cancer Research (Supp.) 50:799s-803s, (1990), "Tc Labeling of Proteins: Initial Evaluation of a Novel Diaminedithiol Bifunctional Chelating Agent".
Wong--Chemistry of Protein Conguation and Cross-Linking, CRC Press, Inc., Boca Raton, Florida, pp. 17-23 (1991), "Reactive Groups of Proteins and Their Modifying Agents".
McCall, et al.--Bioconjugate Chem., 1:222-26 (1990), "Simplified Method for Conjugating Macrocyclic Bifunctional Chelating Agents to Antibodies via 2-Iminothiolane".
Golf, et al.--Bioconjugate Chem., 1:381-86 (1990), Substituted 2-Iminothiolanes: Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased Stability.
Parker, Sybil P., ed., McGraw-Hill Dictionary of Chemical Terms, p. 211 (1984).
Virgolini, et al.--Cancer Res., 54: 690-700 (1994), "Cross-Competition between Vasoactive Intestinal Peptide and Somatostatin for Binding to Tumor Cell Membrane Receptors".
Virgolini, et al.--J. Nucl. Med., 35(5): 97P (1994), "Vasoactive Intestinal Peptide (VIP) Receptor Imaging in the Localization of Intestinal Adenocarcinomas and Endocrine Tumors".(abstract).
Maini, et al.--Nucl. Med. Commun., 14:962-968 (1993), "Somatostatin Receptor Imaging in Small Cell Lung Cancer Using .sup.111 In-DTPA-octreotide: a Preliminary Study".
Lamberts, et al.--New Eng. J. of Med., 323(18): 1246-1249 (1990), "Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors".
Govindan Serengulam V.
Griffiths Gary L.
Hansen Hans L.
Immunomedics Inc.
Jones Dameron
Kight John
LandOfFree
Thiolation of peptides for radionuclide-based radiodetection and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiolation of peptides for radionuclide-based radiodetection and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiolation of peptides for radionuclide-based radiodetection and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-50878